ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests ClearNote Health, a company focused on improving early detection for some of the deadliest cancers, today announced…
Coya Therapeutics Announces Publication Demonstrating Regulatory T-Cell Dysfunction and Systemic Inflammation in Frontotemporal Dementia, Supporting Mechanistic Rationale for COYA 302 Immune-Restoring Therapy Coya Therapeutics, Inc. a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces the publication of a…
PhaseWell Research Acquires Chase Medical Research to Expand Clinical Trial Capabilities in Connecticut PhaseWell Research a multisite clinical research company, today announced the strategic acquisition of Chase Medical Research (“CMR”). Under the leadership of founder, key opinion leader, and lead…
iECURE Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of ECUR-506 Ahead of Planned BLA Submission iECURE, Inc., a clinical-stage genome editing company developing variant-agnostic in vivo targeted gene insertion therapies for the treatment…
GCE® Launches Gascontrol.com Website Showcasing Its Complete Gas Control Portfolio for Speciality, Medical, and Industrial Applications GCE®, a global market leader for gas control equipment, has launched a new website designed to better serve customers across its GCE Specialty, GCE…
Flowserve Appoints Brian Savoy to Board of Directors Flowserve Corporation, a global leader in flow control products and services for infrastructure markets, has announced the appointment of Brian Savoy to its Board of Directors. His appointment became effective on March…
AOM Infusion Joins Limited Distribution Network for QIVIGY® Immune Globulin Therapy AOM Infusion, a leading specialty infusion pharmacy and care provider in the United States, has announced that it has been selected to join the limited distribution network for QIVIGY,…
TIXiMED Expands Program-Related Investment from the Helmsley Charitable Trust to Advance T1D Therapy Development TIXiMED, Inc., a clinical-stage pharmaceutical company focused on developing innovative therapies for diabetes, has announced an expansion of its program-related investment (PRI) from The Leona M.…
DuraPlas Secures Court Ruling Supporting PolarPad® Innovation and Market Competition DuraPlas, a recognized leader in advanced plastic manufacturing and thermal management solutions, has announced a significant legal development following a recent federal court ruling that preserves the company’s ability to…
GrafTech International Ltd., a global producer of high-quality graphite electrode products used in steelmaking and other metal production processes, has announced that it has filed a trade petition with Brazilian authorities requesting an investigation into allegedly unfairly priced imports of…
North American Helium Highlights Need for Stable Supply Amid Qatar Disruptions North American Helium Inc. has commented on the latest global helium supply challenges following production outages in Qatar, emphasizing the need for a more diversified and secure supply chain…
Meiji Seika Pharma Co., Ltd. has announced the initiation of a Phase I clinical trial for ME3241, an innovative anti-PD-1 agonist monoclonal antibody developed through a research collaboration with the Foundation for Biomedical Research and Innovation at Kobe (FBRI). The…